Prelude Capital Management, LLC Aadi Bioscience, Inc. Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 17,797 shares of AADI stock, worth $49,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,797
Previous 17,797
-0.0%
Holding current value
$49,297
Previous $36,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AADI
# of Institutions
54Shares Held
12.7MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.89 Million0.09% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.82 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$5.12 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.85MShares$5.11 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$2.12 Million0.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $58.2M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...